4.8 (215) In stock
PDF) Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Clinician‐ and Patient‐Reported Satisfaction: Long‐Term Observational Results from the ASPIRE Study
Upper Limb Spasticity Treatment For Adults
Journal of Neuropsychiatry
Articles about Revance Therapeutics, Inc.
Revance Reports Positive Results from ASPEN-1 Phase 3 Trial of DaxibotulinumtoxinA for Injection in Cervical Dystonia
Is Daxi the new Botox?
PDF) AbobotulinumtoxinA Versus OnabotulinumtoxinA in Adults with Upper Limb Spasticity: A Randomized, Double-Blind, Crossover Study Protocol
OnabotulinumtoxinA sBLAs for Upper, Lower Limb Spasticity Accepted by FDA
Efficacy and safety of abobotulinumtoxinA in spastic lower limb